S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
Log in

Acasti Pharma News Headlines (NASDAQ:ACST)

$0.74
+0.10 (+15.64 %)
(As of 01/28/2020 04:00 PM ET)
Today's Range
$0.62
Now: $0.74
$0.75
50-Day Range
$0.64
MA: $1.83
$2.87
52-Week Range
$0.51
Now: $0.74
$3.08
Volume3.39 million shs
Average Volume6.26 million shs
Market Capitalization$65.97 million
P/E RatioN/A
Dividend YieldN/A
Beta1.53

Headlines

Acasti Pharma (NASDAQ ACST) News Headlines

Source:
DateHeadline
Zacks: Analysts Expect Acasti Pharma Inc (NASDAQ:ACST) Will Announce Earnings of -$0.13 Per ShareZacks: Analysts Expect Acasti Pharma Inc (NASDAQ:ACST) Will Announce Earnings of -$0.13 Per Share
www.americanbankingnews.com - January 28 at 7:30 AM
Why Amarin Stock Is Poised for a Healthy 2020Why Amarin Stock Is Poised for a Healthy 2020
finance.yahoo.com - January 25 at 3:07 AM
Does Acasti Stock Have a Future?Does Acasti Stock Have a Future?
finance.yahoo.com - January 25 at 3:07 AM
Acasti Pharma (NASDAQ:ACST) Earns Buy Rating from OppenheimerAcasti Pharma (NASDAQ:ACST) Earns Buy Rating from Oppenheimer
www.americanbankingnews.com - January 22 at 12:49 PM
Acasti Pharma (NASDAQ:ACST) Given Daily Coverage Optimism Rating of -4.00Acasti Pharma (NASDAQ:ACST) Given Daily Coverage Optimism Rating of -4.00
www.americanbankingnews.com - January 15 at 6:30 AM
Acasti Shares Slump On Failed Late-Stage Trial, Amarin Moves In SympathyAcasti Shares Slump On Failed Late-Stage Trial, Amarin Moves In Sympathy
www.msn.com - January 13 at 3:27 PM
Amarin Stock Is Surging as Rival Makers of Fish-Oil Heart Drugs Fall ShortAmarin Stock Is Surging as Rival Makers of Fish-Oil Heart Drugs Fall Short
www.barrons.com - January 13 at 3:27 PM
Amarins stock surges, as rival drugs from AstraZeneca, Acasti disappointAmarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint
www.marketwatch.com - January 13 at 3:27 PM
Amarin's stock surges, as rival drugs from AstraZeneca, Acasti disappointAmarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint
finance.yahoo.com - January 13 at 3:27 PM
Acasti Pharma (NASDAQ:ACST) Stock Rating Lowered by B. RileyAcasti Pharma (NASDAQ:ACST) Stock Rating Lowered by B. Riley
www.americanbankingnews.com - January 13 at 9:14 AM
Acasti Pharma Inc (NASDAQ:ACST) Given Consensus Rating of "Buy" by AnalystsAcasti Pharma Inc (NASDAQ:ACST) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - January 9 at 3:42 AM
Echelon Wealth Partners Reaffirms "Buy" Rating for Acasti Pharma (NASDAQ:ACST)Echelon Wealth Partners Reaffirms "Buy" Rating for Acasti Pharma (NASDAQ:ACST)
www.americanbankingnews.com - January 8 at 8:23 AM
Acasti Pharma Inc (NASDAQ:ACST) Expected to Announce Earnings of -$0.07 Per ShareAcasti Pharma Inc (NASDAQ:ACST) Expected to Announce Earnings of -$0.07 Per Share
www.americanbankingnews.com - January 5 at 12:36 PM
Acasti Delays Data Readout For Drug To Treat Elevated TriglyceridesAcasti Delays Data Readout For Drug To Treat Elevated Triglycerides
feeds.benzinga.com - December 24 at 11:51 AM
Acasti Delays Data Readout For Drug To Treat Elevated TriglyceridesAcasti Delay's Data Readout For Drug To Treat Elevated Triglycerides
www.benzinga.com - December 24 at 10:12 AM
IIROC Trading Halt - ACSTIIROC Trading Halt - ACST
finance.yahoo.com - December 23 at 10:30 PM
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPreAcasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
finance.yahoo.com - December 23 at 10:30 PM
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe HypertriglyceridemiaAcasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
finance.yahoo.com - November 26 at 8:34 AM
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Acasti Pharma, Inc.Encode Ideas, L.P. Announces the Initiation of Research Coverage on Acasti Pharma, Inc.
finance.yahoo.com - November 25 at 8:50 AM
Acasti Pharma - Winning The Heart RaceAcasti Pharma - Winning The Heart Race
seekingalpha.com - November 21 at 9:30 AM
Amarin's Shares Down on Underperform Rating by OppenheimerAmarin's Shares Down on Underperform Rating by Oppenheimer
finance.yahoo.com - November 21 at 9:30 AM
Acasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPre’s Novel Mechanism of Action in DiabetesAcasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPre’s Novel Mechanism of Action in Diabetes
finance.yahoo.com - November 18 at 1:35 PM
Acasti Pharma Inc. (ACST) CEO Jan DAlvise on Q2 2020 Results - Earnings Call TranscriptAcasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 12:34 AM
Acasti Pharma Announces Publication of CaPre Pharmacokinetics Study in a Leading Peer-Reviewed JournalAcasti Pharma Announces Publication of CaPre Pharmacokinetics Study in a Leading Peer-Reviewed Journal
finance.yahoo.com - November 7 at 12:15 PM
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare ConferenceAcasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - October 1 at 3:34 PM
Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020
finance.yahoo.com - September 30 at 5:35 PM
Do Insiders Own Lots Of Shares In Acasti Pharma Inc. (CVE:ACST)?Do Insiders Own Lots Of Shares In Acasti Pharma Inc. (CVE:ACST)?
finance.yahoo.com - September 27 at 6:35 AM
Acasti Pharma receives $750,000 funding to develop CaPreAcasti Pharma receives $750,000 funding to develop CaPre
seekingalpha.com - September 9 at 9:55 AM
Acasti Pharma Receives Funding from the Government of Canada to Expand Production CapacityAcasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
finance.yahoo.com - September 9 at 9:55 AM
Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9thAcasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
www.nasdaq.com - September 5 at 5:36 AM
Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9thAcasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
finance.yahoo.com - September 4 at 9:49 AM
Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and Equity Incentive Plans and Other Related Matters Approved at Its AGMAcasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and Equity Incentive Plans and Other Related Matters Approved at Its AGM
finance.yahoo.com - August 29 at 9:33 AM
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020
finance.yahoo.com - August 14 at 8:36 AM
Acasti Pharma, Inc. Institutional OwnershipAcasti Pharma, Inc. Institutional Ownership
www.nasdaq.com - August 9 at 8:16 PM
Acasti Pharma, Inc. (ACST) Pre-Market TradingAcasti Pharma, Inc. (ACST) Pre-Market Trading
www.nasdaq.com - August 9 at 8:16 PM
Acasti Pharma Schedules First Quarter Fiscal 2020 Conference CallAcasti Pharma Schedules First Quarter Fiscal 2020 Conference Call
finance.yahoo.com - August 7 at 11:37 AM
More Players All-In With Acasti PharmaMore Players All-In With Acasti Pharma
seekingalpha.com - July 23 at 3:12 PM
Thinking about buying stock in Aurora Cannabis, Acasti Pharma, Beyond Meat, Aerohive Networks, or Micron Technology?Thinking about buying stock in Aurora Cannabis, Acasti Pharma, Beyond Meat, Aerohive Networks, or Micron Technology?
www.benzinga.com - June 26 at 3:04 PM
Acasti Surges on Year-End FiguresAcasti Surges on Year-End Figures
www.baystreet.ca - June 26 at 3:04 PM
Acasti up 17% after bullish CaPre updateAcasti up 17% after bullish CaPre update
seekingalpha.com - June 26 at 3:04 PM
Acasti Pharma Trades Higher Despite Material UncertaintyAcasti Pharma Trades Higher Despite 'Material Uncertainty'
finance.yahoo.com - June 26 at 3:04 PM
Home-Run Hitters, At Bat With Acasti PharmaHome-Run Hitters, At Bat With Acasti Pharma
seekingalpha.com - June 25 at 12:07 PM
Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid CompositionAcasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition
finance.yahoo.com - June 24 at 3:45 PM
Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference CallAcasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call
feeds.benzinga.com - June 19 at 8:42 AM
Acasti Pharma, Inc. Class A Common Stock Real Time Stock QuotesAcasti Pharma, Inc. Class A Common Stock Real Time Stock Quotes
www.nasdaq.com - June 17 at 3:20 PM
Acasti Issues Shares in Settlement of Claims with Former Chief Executive OfficerAcasti Issues Shares in Settlement of Claims with Former Chief Executive Officer
finance.yahoo.com - May 24 at 5:08 AM
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and IsraelAcasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel
finance.yahoo.com - May 15 at 8:06 AM
Acasti Pharma advancing development of CaPre for high triglyceridesAcasti Pharma advancing development of CaPre for high triglycerides
seekingalpha.com - April 15 at 3:11 PM
Acasti Pharma, Inc. Estimate MomentumAcasti Pharma, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 3:10 PM
Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th - GlobeNewswireAcasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th - GlobeNewswire
www.globenewswire.com - March 13 at 10:49 AM
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Featured Article: Bid-Ask Spread

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel